450 related articles for article (PubMed ID: 10705631)
1. Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
Duvnjak M; Supanc V; Simicević VN; Hrabar D; Troskot B; Smircić-Duvnjak L; Bekavac-Beslin M
Acta Med Croatica; 1999; 53(3):115-8. PubMed ID: 10705631
[TBL] [Abstract][Full Text] [Related]
2. The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
Arcidiacono R; Gambitta P; Rossi A; Grosso C; Bini M; Zanasi G
Endoscopy; 1994 Nov; 26(9):715-8. PubMed ID: 7536155
[TBL] [Abstract][Full Text] [Related]
3. The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
Arvanitidis D; Hatzipanayiotis J; Koutsounopoulos G; Frangou E
Hepatogastroenterology; 1998; 45(19):248-52. PubMed ID: 9496522
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of post-ERCP acute pancreatitis with octreotide].
Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F
G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
Sternlieb JM; Aronchick CA; Retig JN; Dabezies M; Saunders F; Goosenberg E; Infantolino A; Ionna S; Maislin G; Wright SH
Am J Gastroenterol; 1992 Nov; 87(11):1561-6. PubMed ID: 1279967
[TBL] [Abstract][Full Text] [Related]
6. The role of octreotide versus placebo in the prevention of post-ERCP pancreatitis.
Kisli E; Baser M; Aydin M; Guler O
Hepatogastroenterology; 2007; 54(73):250-3. PubMed ID: 17419271
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
[TBL] [Abstract][Full Text] [Related]
8. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: A multicenter, placebo-controlled, randomized clinical trial.
Li ZS; Pan X; Zhang WJ; Gong B; Zhi FC; Guo XG; Li PM; Fan ZN; Sun WS; Shen YZ; Ma SR; Xie WF; Chen MH; Li YQ
Am J Gastroenterol; 2007 Jan; 102(1):46-51. PubMed ID: 17266687
[TBL] [Abstract][Full Text] [Related]
9. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
[TBL] [Abstract][Full Text] [Related]
10. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
[TBL] [Abstract][Full Text] [Related]
11. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
[TBL] [Abstract][Full Text] [Related]
12. Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
Tulassay Z; Döbrönte Z; Prónai L; Zágoni T; Juhász L
Aliment Pharmacol Ther; 1998 Nov; 12(11):1109-12. PubMed ID: 9845400
[TBL] [Abstract][Full Text] [Related]
13. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
14. [Octreotide in the prevention of hyperamylasemia following ERCP (a controlled multicenter study)].
Döbrönte Z; Juhász L; Tulassay Z
Orv Hetil; 1996 Oct; 137(42):2309-12. PubMed ID: 8992429
[TBL] [Abstract][Full Text] [Related]
15. Can somatostatin prevent injection pancreatitis after ERCP?
Persson B; Slezak P; Efendic S; Häggmark A
Hepatogastroenterology; 1992 Jun; 39(3):259-61. PubMed ID: 1380475
[TBL] [Abstract][Full Text] [Related]
16. Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial.
Beauchant M; Ingrand P; Favriel JM; Dupuychaffray JP; Capony P; Moindrot H; Barthet M; Escourrou J; Plane C; Barrioz T; Lacoste L; Ingrand I
Endoscopy; 2008 Aug; 40(8):631-6. PubMed ID: 18680075
[TBL] [Abstract][Full Text] [Related]
17. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
Hardt PD; Fadgyas T; Kress O; Doppl WE; Weber HP; Bimler EA; Temme H; Klör HU
Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604
[TBL] [Abstract][Full Text] [Related]
18. Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
Binmoeller KF; Harris AG; Dumas R; Grimaldi C; Delmont JP
Gut; 1992 Aug; 33(8):1129-33. PubMed ID: 1383099
[TBL] [Abstract][Full Text] [Related]
19. Prospective randomized double-blind placebo-controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis.
Sudhindran S; Bromwich E; Edwards PR
Br J Surg; 2001 Sep; 88(9):1178-82. PubMed ID: 11531863
[TBL] [Abstract][Full Text] [Related]
20. Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
Christoforidis E; Goulimaris I; Kanellos I; Tsalis K; Demetriades C; Betsis D
Endoscopy; 2002 Apr; 34(4):286-92. PubMed ID: 11932783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
